CompletedPhase 2

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

United States10 participantsStarted 2004-05

Plain-language summary

Opioids used to treat chronic pain have a high abuse potential. The purpose of this study is to determine the effectiveness of buprenorphine in treating opioid dependent individuals who abuse opioids that are prescribed for chronic pain.

Who can participate

Age range25 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Current opioid analgesic dependence * History of at least 2 years of oral opiate analgesic use * Prescribed opioids for chronic pain * Pain episode of at least 6 months duration within the 5 years prior to study entry * Available for the duration of the study * Good general health Exclusion Criteria: * Currently using any illicit substance * Meets criteria for alcohol dependence * History of heroin use * History of opiate replacement therapy, including Levo-Alpha Acetyl Methadol (LAAM) or methadone * Evidence of current maximal primary pain

What they're measuring

Substance use

medication compliance

treatment retention

Trial details

NCT IDNCT00218101

SponsorNational Institute on Drug Abuse (NIDA)

Sponsor typeNIH

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Opioid-Related Disorders trials